Strattera (Atomoxetine) for Cocaine Abuse
Strattera (atomoxetine) is not recommended as a treatment for cocaine abuse, even in patients with co-occurring ADHD, because it has not demonstrated efficacy in reducing cocaine use despite improving ADHD symptoms. 1
Why Atomoxetine Fails for Cocaine Use Disorder
The fundamental problem is that atomoxetine improves ADHD symptoms but does not reduce addictive behavior in cocaine users. 1 While atomoxetine is often recommended specifically because it lacks abuse potential—making it theoretically attractive for patients with substance use disorders—this safety profile does not translate into therapeutic benefit for the cocaine addiction itself. 1
What Actually Works: Evidence-Based First-Line Treatment
The most effective treatment for cocaine use disorder is the combination of Contingency Management (CM) plus Community Reinforcement Approach (CRA), which achieves a number needed to treat of 3.7 for abstinence. 2, 3
How This Combined Approach Works:
Contingency Management provides tangible rewards (vouchers/prizes) contingent upon drug-free urine samples, creating immediate positive reinforcement for abstinence 4, 2
Community Reinforcement Approach addresses underlying psychological and social factors through functional analysis, coping-skills training, and social/familial/recreational/vocational reinforcements 4, 2
This combination demonstrates superior outcomes with odds ratios of 7.60 at 12 weeks, 2.84 at end of treatment, and 3.08 at longest follow-up compared to treatment as usual 3
When ADHD Co-Occurs with Cocaine Use Disorder
If your patient truly has both conditions, the treatment algorithm changes:
Pharmacotherapy Considerations:
Stimulant medications (particularly methylphenidate) have demonstrated efficacy for both ADHD symptoms AND cocaine use reduction in this specific population. 5, 6
Sustained-release methylphenidate (40-80 mg daily in divided doses) combined with relapse prevention therapy significantly reduced both ADHD symptoms and cocaine-positive urine toxicologies in a pilot study 5
Methylphenidate maintenance (40-60 mg) decreased positive subjective effects of cocaine and reduced cocaine choice behavior in cocaine abusers with ADHD 6
High doses of stimulant medications show mild to moderate efficacy on ADHD symptoms and may benefit both ADHD symptoms and comorbid cocaine use 1
Critical Implementation Requirements:
Cognitive behavioral therapy MUST be delivered concurrently with any pharmacotherapy—not sequentially—as combined treatment shows superior outcomes (effect sizes g=0.18-0.28). 4
The psychosocial intervention should specifically be CM plus CRA integrated with ADHD-specific pharmacotherapy, rather than used as monotherapy. 4
Common Pitfalls to Avoid
Never rely solely on pharmacotherapy without integrated behavioral interventions, as combined treatment is superior to medication alone 4
Do not use atomoxetine expecting it to reduce cocaine use—while it lacks abuse potential, its efficacy in reducing addictive behavior is not demonstrated 1
Avoid implementing CM without addressing underlying psychological and social factors through CRA, as CM alone shows efficacy during treatment but effects are not sustained at long-term follow-up 4, 3
Do not provide inadequate long-term follow-up—sustained monitoring and support after initial treatment stabilization is critical for preventing relapse 4
Monitoring Strategy
Regular urine drug screening is essential for implementing CM effectively and should be conducted at least 3 times weekly 5
Monitor cardiovascular parameters closely, as cocaine users are at increased risk of cardiovascular dysfunction 2
If using stimulant medications, close supervision is mandatory given the substance use disorder context 5